Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation
Alimentary Pharmacology & Therapeutics · 2025-03 · 61 (5) · 876-885
DOI: 10.1111/apt.18472 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 10.01.2025. Verfasst von Vlasios Gourgiotis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Barts Cancer Institute, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: Barrett Esophagus, Gastroesophageal Reflux, Triage. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHS England.
Abstract (Originalsprache)
Background
Acid reflux is a common presentation in primary care leading to a high volume of referrals to endoscopy that are often normal.
Aims
To determine whether a non‐endoscopic capsule sponge biomarker test could triage patients with low‐risk reflux symptoms, reduce endoscopy waiting lists and identify Barrett's oesophagus in a real‐world setting.
Methods
Patients with reflux symptoms on NHS endoscopy waiting lists who were offered a capsule sponge (test group) between February 2021 and August 2022 were included in this national multicentre prospective cohort study and compared with eligible patients on the standard endoscopy pathway (counterfactual group).
Results
Two thousand one hundred seventy patients from 23 hospitals undertook a capsule sponge triage test and submitted follow‐up data, of whom 1694 (78%) were discharged without endoscopy and 476 (22%) were referred for endoscopy. In a detailed subgroup analysis 1411/1549 (92%) attended and successfully swallowed the capsule of whom 307/1411 (21.8%) required endoscopy. Of 111 patients with positive capsule sponge biomarker results who had endoscopy, 19.8% had Barrett's oesophagus. In comparison, in patients with negative sponge biomarkers who were referred for endoscopy due to ongoing symptoms, none had Barrett's oesophagus ( p = 0.0002). Eighty‐two percent surveyed (267/357) were satisfied with the alternative pathway.
Conclusions
Capsule sponge triage is feasible, safe and acceptable. It substantially reduces the endoscopy burden for routine reflux referrals with a favourable diagnostic yield for Barrett's oesophagus. Longer term follow‐up will help to confidently assess the impact of the programme and place of capsule sponge in the diagnostic pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barts Cancer Institute, Queen Mary University of London, London, UK.
- NHS England, England, UK.
- Early Cancer Insitute, Department of Oncology, University of Cambridge, Cambridge, UK.
- Bedfordshire Hospitals NHS Foundation Trust, Bedfordshire, UK.
- Department of Gastroenterology, East and North Hertfordshire NHS Trust, Hertfordshire, UK.
ORCID-Profile: Danielle L Morris
Förderung
- NHS England
Zitieren
APA
Gourgiotis, V., Graham, C., Foerster, K., NHS England Pilot and NHS England Oversight Group, Fitzgerald, R. C., Harvey, R., & Morris, D. L. (2025). Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation. Alimentary Pharmacology & Therapeutics, 61(5), 876-885. https://doi.org/10.1111/apt.18472
Vancouver
Gourgiotis V, Graham C, Foerster K, NHS England Pilot and NHS England Oversight Group, Fitzgerald RC, Harvey R, et al. Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation. Alimentary Pharmacology & Therapeutics. 2025;61(5):876-885. doi:10.1111/apt.18472
BibTeX
@article{Gourgiotis2025,
author = {Gourgiotis, Vlasios and Graham, Charlotte and Foerster, Kristen and NHS England Pilot and NHS England Oversight Group, NHS England Pilot and NHS England Oversight Group and Fitzgerald, Rebecca C and Harvey, Rory and Morris, Danielle L},
title = {Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
volume = {61},
number = {5},
pages = {876--885},
doi = {10.1111/apt.18472}
}
EUVIMED